FR2878442B1 - THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION - Google Patents

THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION

Info

Publication number
FR2878442B1
FR2878442B1 FR0412644A FR0412644A FR2878442B1 FR 2878442 B1 FR2878442 B1 FR 2878442B1 FR 0412644 A FR0412644 A FR 0412644A FR 0412644 A FR0412644 A FR 0412644A FR 2878442 B1 FR2878442 B1 FR 2878442B1
Authority
FR
France
Prior art keywords
thieno
preparation
compositions containing
containing same
substituted pyrazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0412644A
Other languages
English (en)
Other versions
FR2878442A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0412644A priority Critical patent/FR2878442B1/fr
Priority to JP2007542047A priority patent/JP2008521781A/ja
Priority to PCT/FR2005/002933 priority patent/WO2006056697A1/fr
Priority to EP05822880A priority patent/EP1824859A1/fr
Publication of FR2878442A1 publication Critical patent/FR2878442A1/fr
Priority to US11/752,612 priority patent/US7884123B2/en
Application granted granted Critical
Publication of FR2878442B1 publication Critical patent/FR2878442B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
FR0412644A 2004-11-29 2004-11-29 THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION Expired - Fee Related FR2878442B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0412644A FR2878442B1 (fr) 2004-11-29 2004-11-29 THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION
JP2007542047A JP2008521781A (ja) 2004-11-29 2005-11-25 置換チエノ［２，３−ｃ］ピラゾール、これらの製造のための方法、これを含む組成物およびこの使用
PCT/FR2005/002933 WO2006056697A1 (fr) 2004-11-29 2005-11-25 THIENO[2,3-c]PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION
EP05822880A EP1824859A1 (fr) 2004-11-29 2005-11-25 Thieno[2,3-c]pyrazoles substitues, procede de preparation, compositions les contenant et utilisation
US11/752,612 US7884123B2 (en) 2004-11-29 2007-05-23 Substituted thieno[2,3-c]pyrazoles, process for preparing them, compositions containing them, and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0412644A FR2878442B1 (fr) 2004-11-29 2004-11-29 THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION

Publications (2)

Publication Number Publication Date
FR2878442A1 FR2878442A1 (fr) 2006-06-02
FR2878442B1 true FR2878442B1 (fr) 2008-10-24

Family

ID=34951993

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0412644A Expired - Fee Related FR2878442B1 (fr) 2004-11-29 2004-11-29 THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION

Country Status (5)

Country Link
US (1) US7884123B2 (fr)
EP (1) EP1824859A1 (fr)
JP (1) JP2008521781A (fr)
FR (1) FR2878442B1 (fr)
WO (1) WO2006056697A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007009898A1 (fr) * 2005-07-19 2007-01-25 Nerviano Medical Sciences S.R.L. Composes 1h-thieno[2,3-c]pyrazole servant d'inhibiteurs de kinase
FR3000403B1 (fr) * 2012-12-28 2015-02-06 Galderma Res & Dev Composition dermatologique comprenant un inhibiteur de pde7 sous forme solubilisee, son procede de preparation et son utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
EP1307462A2 (fr) * 2000-08-09 2003-05-07 Agouron Pharmaceuticals, Inc. Composes pyrazole-thiazole, compositions pharmaceutiques les contenant, et leurs procedes d'utilisation pour inhiber les kinases cyclino-dependantes
AU2003241925A1 (en) * 2002-05-31 2003-12-19 Eisai R&D Management Co., Ltd. Pyrazole compound and medicinal composition containing the same
BR0312722A (pt) * 2002-07-17 2005-05-10 Pharmacia Italia Spa Derivados de pirazol heterobicìclico como inibidores de qinase
AU2003250040A1 (en) * 2002-07-25 2004-02-23 Pharmacia Italia S.P.A Condensed heterocyclic pyrazole derivatives as kinase inhibitors
US20050026984A1 (en) * 2003-07-29 2005-02-03 Aventis Pharma S.A. Substituted thieno [2,3-c] pyrazoles and their use as medicinal products

Also Published As

Publication number Publication date
US20080058402A1 (en) 2008-03-06
US7884123B2 (en) 2011-02-08
WO2006056697A1 (fr) 2006-06-01
JP2008521781A (ja) 2008-06-26
FR2878442A1 (fr) 2006-06-02
WO2006056697A8 (fr) 2007-07-05
EP1824859A1 (fr) 2007-08-29

Similar Documents

Publication Publication Date Title
FR2884821B1 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
MA27366A1 (fr) Nouveaux derives de thiophenylglycoside, methodes pour leur production, medicaments contenant lesdits composes et leur utilisation
FR2885904B1 (fr) Nouveaux derives du fluorene, compositions les contenant et utilisation
MA28337A1 (fr) Derives de l'acide 7-phenylamino-4-quinolone-3-carboxylique, methodes pour leur production et leur utilisation en tant que medicaments
IL192937A0 (en) Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same
HK1089436A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
IL154306A0 (en) Pharmaceutical compositions comprising thieno [2,3-c] pyridine derivatives and use thereof
ZA200509869B (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2882751B1 (fr) Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
PL1746097T3 (pl) Skondensowane heterocykle 1,4-dihydropirydynowe, sposób ich wytwarzania, zastosowanie i zawierające je kompozycje
MA26943A1 (fr) Aminoalkylbenzoyl-benzofuranes ou benzothiophenes, leur procede de preparation et les compositions les contenant.
MA27252A1 (fr) Diphenylazetidinones substituees, leur procede de preparation, medicaments contenant ces composes et leur utilisation
FR2908409B1 (fr) Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
EP1651651A4 (fr) Nanoparticules comprenant des derives de cucurbiturile, composition pharmaceutique contenant ces nanoparticules, ainsi que leurs methodes de preparation
ATE337317T1 (de) Imidazopyrin-derivate, verfahren zu ihrer herstellung and sie enthaltende pharmazeutische zusamensetzungen
FR2807052B1 (fr) Compositions silico-acryliques, leur procede de preparation et leur utilisation
FR2880891B1 (fr) Pyrazolo pyridines substituees, compositions les contenant, procede de fabrication et utilisation
ATE316968T1 (de) P-thienylbenzyl-amide als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
FR2878849B1 (fr) Indoles substitues, compositions les contenant, procede de fabrication et utilisation
FR2881742B1 (fr) Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
FR2821846B1 (fr) Polymere anti-reflechissant,composition de revetement le contenant et procede de preparation de ce polymere et cette composition
ATA15742001A (de) Einrichtung zur gewinnung von samenzellen aus samenflüssigkeit
FR2873377B1 (fr) Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation
FR2878442B1 (fr) THIENO(2,3-c)PYRAZOLES SUBSTITUES, PROCEDE DE PREPARATION, COMPOSITIONS LES CONTENANT ET UTILISATION

Legal Events

Date Code Title Description
RN Application for restoration
FC Decision of inpi director general to approve request for restoration
ST Notification of lapse

Effective date: 20120731